According to SPECT data, in addition toclear visualization of HER2-positive tumors, weak accumulation of the studieddrug was observed in HER2-negative foci, attributable to the presence of acertain amount of the HER2 receptor on the surface of tumor cells. This evidence concerns the gene ERBB2 and neoplasm.